Open AccessSAT-443 Osilodrostat Has No Clinically Relevant Effect on the Pharmacokinetic (PK) Profile of a Monophasic Oral Contraceptive in Healthy Females Receiving Cortisol Replacement Therapy
Author(s) -
Astrid Breitschaft,
Libuse Tauchmanovà,
Kevin Han,
Susan Atkinson,
Heidi Nauwelaerts,
Tirtha Sengupta,
Ivanka Zic,
Lisa Burgmeyer,
Alberto M Pedroncelli
Publication year - 2019
Publication title -
journal of the endocrine society
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.046
H-Index - 20
ISSN - 2472-1972
DOI - 10.1210/js.2019-sat-443
Subject(s) - medicine , cmax , pharmacokinetics , tolerability , levonorgestrel , hydrocortisone , population , endocrinology , adverse effect , family planning , environmental health , research methodology
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom